Notify me when Daniella Beckman files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | Chief Financial Officer | $2,376,896 | -$126,531 | -5.1% | 02 Feb 2026 |
| BPMC | Blueprint Medicines Corp | Director | $0 | 17 Jul 2025 | ||
| TBIO | Translate Bio, Inc. | Director | 14 Sep 2021 | |||
| UPB | Upstream Bio, Inc. | Director | 10 Jun 2025 | |||
| VOR | Vor Biopharma Inc. | Director | 22 May 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|